Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Faeth Therapeutics granted three new employees options to purchase an aggregate of 17,000 shares as employment inducement awards under Nasdaq Listing Rule 5635(c)(4). The options carry a $19.44 exercise price equal to the grant-date closing price, with standard four-year vesting (25% after one year, then 36 monthly installments) and a ten-year term.
Key figures
- Exercise price
- 19.44
- Options granted
- 17000
- Option term years
- 10
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.